About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


1 1 (February 18, 2021)

handle is hein.amenin/aeiadsy0001 and id is 1 raw text is: Key Points /Arne ran CO l[19 vaccine technolgy iA the wvord's bestL Moreover, potential com- petitor face greater obstacles in efficacy, tra spareny, and production. a Once vaccination a. nome is wuel along, 0he oe Bider ac ministration can subsidiLe international distrouuton of Amer cican vaccines. In addition to humanitarian motivuc, there is aiso an impor -nt `oreign poiicy pportunaity US-China comp-eition has intensified during the pandernc and coud :ren;sify further this decade. China caused the COVID -19 probm wn ie the US can lead in solving it- a poweiruel contrast The single rmost im porant area of competion is Southeast Asia. The populous countries of Indonesia, the Philippines, and Vietnram naturaiiy face vaccination challenges, Ameni- can assistance woculd have substanteal value. After a eai o a d evastating hea lth cri sis, economic wreckage, and foreign attempt s to capitalize on American misfortunes, the Baden administration is looking for ways to reestabi sh world leadership. The US pharmaceutical industry has provided Pres- ident toe iden with a powerful tool to protect publac health: he w rids best vaccine technology Combined with prduction capacity to match or exceed all global comnpettors, this technology slohld also he leveraged for diplomatic gain, While health and econibc recovery at horme are the first goals, the Us should immediately planr to subsidize CVID--9 vaccine production for international distribution. Humanitarian consid- erations are in'rinsic in this decision. But Wash- ington should also prioritize distribution nased on geosmitegic goals. Proximity makes Mexico an obvious choke for the irst recipient of extensive vaccine aid. After that, the US should turn to gaining geopolitical advantage mi its competition with China1. Ti\ moves the large Southeast Asian countries of Ind onesia, the Philippines, and Vietnam to the top of the list tor vaccine assistance. Vaccine Quality The US has the opportunity for a major foreign policy success. American vaccine quality will likely remain globally suprerne, and American produc- tion capacity will be competitive with the People's Republic of China (PRC). This is not a surprise: The American innovation system is unmatched. Years before COVID-to emerged, research institutions and pharmaceutical